Published: Apr 10, 2026
Written by Klarity Editorial Team
Published: Apr 10, 2026

If you’re struggling with binge eating disorder (BED), you’ve likely wondered whether you can access treatment without the barriers of traditional in-person appointments. The short answer is yes—telehealth has opened doors to effective BED treatment, including prescription medications, for millions of Americans. But navigating the rules around online prescribing can feel overwhelming, especially with recent regulatory changes and state-by-state variations.
This comprehensive guide will walk you through everything you need to know about getting medication for binge eating disorder via telehealth in 2026, including which medications are available, how the legal landscape works, and what to expect from your virtual treatment journey.
Before diving into telehealth specifics, it’s important to understand what binge eating disorder is and how it’s typically treated.
Binge eating disorder is the most common eating disorder in the United States, affecting approximately 2.8 million Americans. According to DSM-5 criteria, BED is characterized by:
Unlike other eating disorders, BED isn’t defined by body weight or appearance—people of all sizes can experience this condition.
Evidence-based treatment for BED typically includes a combination of:
Psychotherapy: Cognitive-behavioral therapy (CBT) and dialectical behavior therapy (DBT) have shown strong effectiveness in reducing binge episodes and addressing underlying emotional triggers.
Nutritional counseling: Working with a registered dietitian can help establish regular eating patterns and reduce the restrict-binge cycle.
Medication: While only one medication (Vyvanse, a controlled stimulant) has FDA approval specifically for BED, several non-controlled medications are commonly used off-label with good results.
Support groups: Peer support can provide accountability and reduce the isolation many people with BED experience.
The good news for patients seeking BED treatment is that non-controlled medications can be legally prescribed via telehealth in all 50 states, as long as the provider is licensed in your state and conducts an appropriate evaluation.
At the federal level, the Drug Enforcement Administration (DEA) regulates prescribing of controlled substances through the Ryan Haight Act. However, this law does not apply to non-controlled medications like those commonly used for BED treatment.
The COVID-19 public health emergency led to temporary flexibilities for controlled substance prescribing via telehealth, which have been extended through December 31, 2026. While these extensions primarily affect medications like ADHD stimulants and opioids, they’ve also helped normalize and expand telehealth infrastructure overall.
For the non-controlled medications used in BED treatment—such as Topamax (topiramate) and Wellbutrin (bupropion)—there has never been a federal requirement for an in-person visit before prescribing. This means telehealth providers have consistent, stable authorization to prescribe these medications remotely.
While federal law sets the baseline, individual states can impose additional requirements. The landscape varies considerably:
Most Permissive States: California, New York, Michigan, and Wisconsin have no in-person visit requirement for non-controlled medications. California even allows asynchronous (questionnaire-based) evaluations if they meet the standard of care.
Periodic In-Person Requirements: A few states like Alabama, Georgia, and New Hampshire require patients receiving ongoing telehealth care to have an in-person visit within 12 months. However, this visit can often be completed with any healthcare provider, not necessarily your prescribing telehealth clinician.
No Special Restrictions: The majority of states (including Texas, Florida, Delaware, and South Carolina) allow telehealth prescribing of non-controlled medications as long as the provider conducts an appropriate clinical evaluation—which can be done entirely via video.
Your telehealth provider can be:
This means you have access to a wide range of qualified providers through telehealth platforms, increasing appointment availability and reducing wait times.
While Vyvanse (lisdexamfetamine) is the only FDA-approved medication specifically for binge eating disorder, it’s a Schedule II controlled substance with tighter prescribing restrictions. Most telehealth platforms focus on two well-researched, non-controlled alternatives:
What it is: Originally FDA-approved for seizure disorders and migraine prevention, topiramate has shown promise in reducing binge eating episodes.
How it works: Topiramate affects neurotransmitter activity in the brain, particularly GABA and glutamate, which may help with impulse control and reduce food cravings.
Typical dosing: Treatment usually starts at a low dose (25mg daily) and gradually increases to 100-200mg daily, divided into two doses. The gradual titration helps minimize side effects.
Benefits for BED: Research suggests topiramate can reduce binge frequency and may support modest weight loss, which some patients find motivating.
Important considerations:
What it is: FDA-approved for depression and smoking cessation, bupropion has been studied for BED with encouraging results.
How it works: As an atypical antidepressant, bupropion affects dopamine and norepinephrine, which can help regulate mood and potentially reduce binge urges.
Typical dosing: Extended-release formulations (Wellbutrin XL) are usually started at 150mg daily and may be increased to 300mg after several weeks.
Benefits for BED: Some studies show bupropion can reduce binge frequency and may have a modest appetite-suppressing effect for some individuals.
Important considerations:
Both of these medications are prescribed ‘off-label’ for BED, meaning they’re used for a condition other than what the FDA originally approved them for. This is completely legal and extremely common in medicine—in fact, off-label prescribing accounts for approximately 20% of all prescriptions written in the United States.
Clinical research supports the use of both topiramate and bupropion for BED, and reputable telehealth providers will:
Getting BED medication through telehealth isn’t—and shouldn’t be—as simple as filling out a questionnaire and receiving a prescription. Legitimate providers follow a thorough evaluation process.
Your first appointment will typically last 30-60 minutes and include:
Diagnostic screening: Expect detailed questions about your eating patterns, including:
Medical history review: Your provider will ask about:
Safety screening: Critical questions to determine if you’re a good candidate for telehealth treatment:
Mental status assessment: The provider will evaluate your current mental state, including mood, thought processes, and judgment.
Don’t be surprised when your telehealth provider verifies your identity and location. This isn’t distrust—it’s a regulatory requirement in many states to ensure:
If medication is appropriate, your provider should discuss:
A red flag would be a provider who rushes through this conversation or doesn’t discuss non-medication options.
The telehealth boom has brought both innovation and, unfortunately, some questionable practices. Here’s how to identify quality care:
✅ Thorough evaluation: Initial appointments of at least 30 minutes with comprehensive questions
✅ Licensed providers: Clear information about your provider’s credentials and state licensure
✅ Transparency about off-label use: Honest discussion when medications are prescribed for non-FDA-approved indications
✅ Multiple treatment options discussed: Medication isn’t presented as the only solution
✅ Regular follow-up required: Scheduled check-ins, especially when starting new medication
✅ Access to support: Messaging systems or nurse lines for questions between appointments
✅ Privacy compliance: HIPAA-compliant platforms and clear privacy policies
✅ Pharmacy integration: Prescriptions sent to established pharmacies, not shipped from the company itself
🚩 Prescription guarantees: Any service promising medication before evaluation
🚩 Minimal assessment: Quick questionnaires without live provider interaction
🚩 No discussion of alternatives: Pushing medication without mentioning therapy or other options
🚩 Controlled substance focus: Legitimate BED telehealth services generally don’t prescribe stimulants online
🚩 Pressure tactics: Urgency to start treatment or subscribe immediately
🚩 Direct medication sales: Company ships pills directly rather than using licensed pharmacies
🚩 No follow-up required: One-and-done prescribing without monitoring
🚩 Unlicensed providers: Inability to verify provider credentials
The 2024 indictment of executives from a telehealth startup for unsafe ADHD medication prescribing serves as a cautionary tale. The company allegedly provided stimulant prescriptions after 30-minute evaluations without adequate safeguards, contributing to the Adderall shortage and putting patients at risk. This enforcement action signals increased scrutiny of telehealth prescribing practices—which ultimately protects patients when done right.
Most states operate Prescription Drug Monitoring Programs (PDMPs) that track controlled substance prescriptions. While topiramate and bupropion are not controlled substances and therefore don’t trigger mandatory PDMP checks in most states, responsible providers may still review your medication history as good practice.
This review helps ensure:
This is a safety measure, not an invasion of privacy.
After your evaluation, your provider will send your prescription electronically to the pharmacy of your choice. You can typically:
Cost considerations: Without insurance, topiramate is relatively affordable (often $10-30/month for generic), while bupropion extended-release can range from $15-100/month depending on formulation. Prices vary significantly by pharmacy, so it’s worth comparing.
Because these are non-controlled medications, providers can typically authorize refills for 6-12 months, depending on state regulations. However, expect regular follow-up appointments, typically:
Some states (Alabama, Georgia, New Hampshire) require an in-person visit within 12 months for ongoing telehealth care, but this can often be satisfied by seeing any local healthcare provider for a routine check-up.
Telehealth expands access, but it’s not appropriate for everyone. You may need in-person evaluation if you have:
Contraindications to common medications:
Medical complexity requiring in-person monitoring:
Safety concerns:
Need for controlled substances: If your provider determines you need Vyvanse (the FDA-approved stimulant for BED), current telehealth regulations make this more difficult to prescribe remotely, and you may need an in-person evaluation.
Preference for specialized eating disorder programs: Some patients benefit from intensive outpatient programs, partial hospitalization, or residential treatment that addresses BED comprehensively with daily structure and support.
A quality telehealth provider will recognize when you need a higher level of care and provide appropriate referrals.
At Klarity Health, we’ve designed our telehealth platform specifically to address the barriers that keep people from getting eating disorder treatment. Our approach includes:
Provider availability: We maintain a network of board-certified psychiatrists, psychiatric nurse practitioners, and licensed therapists with eating disorder expertise across multiple states, with appointment times often available within 48 hours.
Transparent pricing: Whether you’re using insurance or paying cash, you’ll know the cost upfront—no surprise bills. Our cash-pay rates are competitive and clearly posted, and we accept most major insurance plans.
Integrated care: We don’t just prescribe medication. Our model encourages combining medication management with therapy, and our platform makes it easy to coordinate between providers.
Evidence-based approach: Our providers follow current clinical guidelines and prioritize your safety with thorough evaluations, regular monitoring, and clear communication about risks and benefits.
Flexibility: We understand that binge eating disorder affects busy professionals, parents, students, and people with varying schedules. Evening and weekend appointments, along with secure messaging between visits, make staying engaged with treatment more manageable.
Most insurance plans now cover telehealth at the same rate as in-person visits, thanks to policies adopted during the pandemic that have been made permanent or extended. However, coverage varies by plan, so check your specific benefits. Klarity Health can verify your coverage before your first appointment.
This varies by individual and medication. Some people notice reduced binge urges within 2-4 weeks, while others may need 6-8 weeks at an optimal dose. It’s important to maintain realistic expectations—medication is a tool that works best alongside therapy and behavioral changes, not a magic solution.
This should always be discussed with your provider. Some people benefit from 6-12 months of treatment while developing new coping strategies, then successfully taper off. Others find that longer-term treatment helps maintain progress. Abrupt discontinuation, especially of topiramate, can be dangerous.
This is exactly where telehealth shines. Geographic barriers that once left people in underserved areas without specialized care are now much less limiting. As long as you have internet access and your provider is licensed in your state, you can access the same quality of care as someone in a major city.
If you move to a different state, your current telehealth provider may not be able to continue treating you unless they’re licensed in your new state. However, you can transition to a new provider within the same platform who is licensed in your new location, often with warm handoff communication to maintain continuity.
Binge eating disorder is a serious but treatable condition. The expansion of telehealth has made evidence-based treatment—including medication when appropriate—more accessible than ever before. Whether you’re just starting to explore treatment options or you’ve tried other approaches without success, telehealth offers a convenient, private, and effective pathway to care.
Remember that medication is just one component of comprehensive BED treatment. The most successful approaches typically combine:
Ready to get started? Schedule a comprehensive evaluation with a licensed provider who can assess whether telehealth BED treatment is right for you. At Klarity Health, our team is here to provide personalized, evidence-based care that fits your life—with transparent pricing, flexible scheduling, and providers who genuinely understand eating disorders.
You don’t have to struggle alone, and you don’t have to wait weeks for an appointment or travel hours to see a specialist. Effective help is available right now, from wherever you are.
Verified as of: January 4, 2026
DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine.
States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.
Sources newer than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.
Flagged for follow-up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.
HHS Press Room. (2026, January 2). DEA extends telemedicine prescribing waivers through December 31, 2026. Retrieved from https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Sheppard Mullin Healthcare Law Blog. (2025, August). Telehealth and in-person visits: Tracking federal and state updates to pandemic-era telehealth exceptions. Retrieved from https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/
Center for Connected Health Policy. (2025, November-December). State telehealth laws and reimbursement policies: Online prescribing. Retrieved from https://www.cchpca.org/topic/online-prescribing/
Health Jobs Nationwide Blog. (2025). State-by-state guide: Expanding roles for PAs and NPs (Updated 2025). Retrieved from https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/
National Law Review. (2025). Telehealth and in-person visits: Tracking federal and state updates to pandemic-era telehealth exceptions. Retrieved from https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era
Find the right provider for your needs — select your state to find expert care near you.